Unsuccessful trials of therapies for Alzheimer's disease

Affiliations

¹ Institute of Neurology, Dementia Research Centre, University College London, London WC1E 6BT, UK. Electronic address: j.schott@ucl.ac.uk.
² Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
³ Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA.
⁴ Division of Psychiatry, Faculty of Brain Sciences, University College London, London WC1E 6BT, UK.
⁵ Institute of Neurology, Dementia Research Centre, University College London, London WC1E 6BT, UK.

Comment

Jonathan M Schott et al. Lancet. 2019.

. 2019 Jan 5;393(10166):29.

doi: 10.1016/S0140-6736(18)31896-8.

¹ Institute of Neurology, Dementia Research Centre, University College London, London WC1E 6BT, UK. Electronic address: j.schott@ucl.ac.uk.
² Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
³ Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA.
⁴ Division of Psychiatry, Faculty of Brain Sciences, University College London, London WC1E 6BT, UK.
⁵ Institute of Neurology, Dementia Research Centre, University College London, London WC1E 6BT, UK.

No abstract available

Comment in

Unsuccessful trials of therapies for Alzheimer's disease - Authors' reply.
Anderson RM, Hadjichrysanthou C, Evans S, McRae-McKee K, Wong MM. Anderson RM, et al. Lancet. 2019 Jan 5;393(10166):29-30. doi: 10.1016/S0140-6736(18)31897-X. Lancet. 2019. PMID: 30614455 No abstract available.

Why do so many clinical trials of therapies for Alzheimer's disease fail?
Anderson RM, Hadjichrysanthou C, Evans S, Wong MM. Anderson RM, et al. Lancet. 2017 Nov 25;390(10110):2327-2329. doi: 10.1016/S0140-6736(17)32399-1. Lancet. 2017. PMID: 29185425 No abstract available.